Ugp2 Rat (S)-nicotine increases expression ISO UGP2 (Homo sapiens) 6480464 Nicotine results in increased expression of UGP2 mRNA CTD PMID:18247414 Ugp2 Rat 1,2-dimethylhydrazine multiple interactions ISO Ugp2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UGP2 mRNA CTD PMID:22206623 Ugp2 Rat 1,2-dimethylhydrazine decreases expression ISO Ugp2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of UGP2 mRNA CTD PMID:22206623 Ugp2 Rat 17alpha-ethynylestradiol increases expression ISO Ugp2 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of UGP2 mRNA CTD PMID:17942748 Ugp2 Rat 17alpha-ethynylestradiol multiple interactions ISO Ugp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGP2 mRNA CTD PMID:17942748 Ugp2 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of UGP2 mRNA CTD PMID:32145629 Ugp2 Rat 17beta-estradiol decreases expression ISO Ugp2 (Mus musculus) 6480464 Estradiol results in decreased expression of UGP2 mRNA CTD PMID:39298647 Ugp2 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ugp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UGP2 mRNA CTD PMID:17942748 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of UGP2 mRNA CTD PMID:34747641 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ugp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of UGP2 mRNA CTD PMID:21570461 more ... Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGP2 mRNA CTD PMID:21215274 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ugp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGP2 mRNA CTD PMID:19770486 Ugp2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ugp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of UGP2 mRNA CTD PMID:19465110 Ugp2 Rat 2,6-dimethoxyphenol multiple interactions ISO UGP2 (Homo sapiens) 6480464 [pyrogallol 1 more ... CTD PMID:38598786 Ugp2 Rat 2-bromohexadecanoic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UGP2 protein] CTD PMID:38195004 Ugp2 Rat 2-methylcholine affects expression ISO UGP2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of UGP2 mRNA CTD PMID:21179406 Ugp2 Rat 2-naphthylamine increases expression ISO UGP2 (Homo sapiens) 6480464 2-Naphthylamine results in increased expression of UGP2 mRNA CTD PMID:18247414 Ugp2 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of UGP2 protein CTD PMID:34915118 Ugp2 Rat 3-phenylprop-2-enal increases expression ISO UGP2 (Homo sapiens) 6480464 cinnamaldehyde results in increased expression of UGP2 mRNA CTD PMID:17178418 Ugp2 Rat 4,4'-diaminodiphenylmethane decreases expression ISO Ugp2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of UGP2 mRNA CTD PMID:18648102 Ugp2 Rat 4,4'-sulfonyldiphenol increases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol S results in increased expression of UGP2 protein CTD PMID:34186270 Ugp2 Rat 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of UGP2 mRNA CTD PMID:21346803 Ugp2 Rat 5-aza-2'-deoxycytidine affects expression ISO UGP2 (Homo sapiens) 6480464 Decitabine affects the expression of UGP2 mRNA CTD PMID:23300844 Ugp2 Rat 5-aza-2'-deoxycytidine multiple interactions ISO UGP2 (Homo sapiens) 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of UGP2 mRNA] CTD PMID:21095227 Ugp2 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of UGP2 mRNA CTD PMID:31881176 Ugp2 Rat acrolein multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of UGP2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of UGP2 mRNA CTD PMID:32699268 Ugp2 Rat aflatoxin B1 decreases expression ISO Ugp2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of UGP2 mRNA CTD PMID:19770486 Ugp2 Rat all-trans-retinoic acid increases expression ISO UGP2 (Homo sapiens) 6480464 Tretinoin results in increased expression of UGP2 mRNA CTD PMID:33167477 Ugp2 Rat alpha-pinene multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of UGP2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of UGP2 mRNA CTD PMID:32699268 Ugp2 Rat aristolochic acid A increases expression ISO UGP2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of UGP2 protein CTD PMID:33212167 Ugp2 Rat aristolochic acid A decreases expression ISO UGP2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of UGP2 mRNA CTD PMID:33212167 Ugp2 Rat arsenite(3-) multiple interactions ISO UGP2 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to UGP2 mRNA] CTD PMID:32406909 Ugp2 Rat benzo[a]pyrene increases expression ISO UGP2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of UGP2 mRNA CTD PMID:18247414 Ugp2 Rat benzo[a]pyrene decreases expression ISO Ugp2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of UGP2 mRNA CTD PMID:19770486 Ugp2 Rat beta-lapachone increases expression ISO UGP2 (Homo sapiens) 6480464 beta-lapachone results in increased expression of UGP2 mRNA CTD PMID:38218311 Ugp2 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Ugp2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of UGP2 mRNA CTD PMID:19850644 Ugp2 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Ugp2 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of UGP2 mRNA] CTD PMID:19850644 Ugp2 Rat bisphenol A increases expression ISO Ugp2 (Mus musculus) 6480464 bisphenol A results in increased expression of UGP2 mRNA CTD PMID:26063408 Ugp2 Rat bisphenol A decreases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of UGP2 protein CTD PMID:34186270 Ugp2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UGP2 mRNA CTD PMID:32145629 and PMID:34947998 Ugp2 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UGP2 mRNA CTD PMID:30903817 Ugp2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UGP2 mRNA CTD PMID:25181051 Ugp2 Rat bisphenol AF increases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol AF results in increased expression of UGP2 protein CTD PMID:34186270 Ugp2 Rat Bisphenol B increases expression ISO UGP2 (Homo sapiens) 6480464 bisphenol B results in increased expression of UGP2 protein CTD PMID:34186270 Ugp2 Rat Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of UGP2 protein CTD PMID:28903499 Ugp2 Rat cadmium atom multiple interactions ISO UGP2 (Homo sapiens) 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UGP2 protein] more ... CTD PMID:35301059 and PMID:38195004 Ugp2 Rat cadmium dichloride increases expression ISO UGP2 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of UGP2 protein CTD PMID:24527689 Ugp2 Rat cadmium dichloride multiple interactions ISO UGP2 (Homo sapiens) 6480464 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of UGP2 protein] more ... CTD PMID:35301059 and PMID:38195004 Ugp2 Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of UGP2 mRNA CTD PMID:25993096 Ugp2 Rat carbon nanotube decreases expression ISO Ugp2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 Ugp2 Rat chenodeoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat chlorpyrifos decreases expression ISO Ugp2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of UGP2 mRNA CTD PMID:37019170 Ugp2 Rat cisplatin affects expression ISO UGP2 (Homo sapiens) 6480464 Cisplatin affects the expression of UGP2 mRNA CTD PMID:23300844 Ugp2 Rat clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of UGP2 protein CTD PMID:16470657 Ugp2 Rat clofibrate decreases expression ISO Ugp2 (Mus musculus) 6480464 Clofibrate results in decreased expression of UGP2 mRNA CTD PMID:23811191 Ugp2 Rat clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of UGP2 mRNA CTD PMID:17602206 Ugp2 Rat copper(II) chloride increases expression ISO UGP2 (Homo sapiens) 6480464 cupric chloride results in increased expression of UGP2 mRNA CTD PMID:38568856 Ugp2 Rat copper(II) sulfate decreases expression ISO UGP2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of UGP2 mRNA CTD PMID:19549813 Ugp2 Rat crocidolite asbestos affects expression ISO UGP2 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of UGP2 mRNA CTD PMID:24160326 Ugp2 Rat cyclosporin A decreases expression ISO Ugp2 (Mus musculus) 6480464 Cyclosporine results in decreased expression of UGP2 mRNA CTD PMID:19770486 Ugp2 Rat cyclosporin A multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat cyclosporin A increases expression ISO UGP2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of UGP2 mRNA CTD PMID:25562108 Ugp2 Rat deoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat dexamethasone increases expression ISO UGP2 (Homo sapiens) 6480464 Dexamethasone results in increased expression of UGP2 mRNA CTD PMID:25047013 Ugp2 Rat Dibutyl phosphate affects expression ISO UGP2 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of UGP2 mRNA CTD PMID:37042841 Ugp2 Rat dibutyl phthalate decreases expression ISO Ugp2 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of UGP2 mRNA CTD PMID:21266533 Ugp2 Rat dichlorvos decreases activity EXP 6480464 Dichlorvos results in decreased activity of UGP2 protein CTD PMID:222008 Ugp2 Rat dicrotophos decreases expression ISO UGP2 (Homo sapiens) 6480464 dicrotophos results in decreased expression of UGP2 mRNA CTD PMID:28302478 Ugp2 Rat dorsomorphin multiple interactions ISO UGP2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Ugp2 Rat ellagic acid decreases expression ISO UGP2 (Homo sapiens) 6480464 Ellagic Acid results in decreased expression of UGP2 mRNA CTD PMID:12002526 Ugp2 Rat entinostat increases expression ISO UGP2 (Homo sapiens) 6480464 entinostat results in increased expression of UGP2 mRNA CTD PMID:26272509 Ugp2 Rat entinostat multiple interactions ISO UGP2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGP2 mRNA CTD PMID:27188386 Ugp2 Rat ethanol affects expression ISO Ugp2 (Mus musculus) 6480464 Ethanol affects the expression of UGP2 mRNA CTD PMID:30319688 Ugp2 Rat flucloxacillin affects binding ISO UGP2 (Homo sapiens) 6480464 Floxacillin binds to UGP2 protein CTD PMID:36782357 Ugp2 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of UGP2 mRNA CTD PMID:24793618 Ugp2 Rat folic acid multiple interactions ISO Ugp2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UGP2 mRNA CTD PMID:22206623 Ugp2 Rat FR900359 increases phosphorylation ISO UGP2 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of UGP2 protein CTD PMID:37730182 Ugp2 Rat furfural multiple interactions ISO UGP2 (Homo sapiens) 6480464 [pyrogallol 1 more ... CTD PMID:38598786 Ugp2 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of UGP2 mRNA CTD PMID:22061828 Ugp2 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of UGP2 mRNA CTD PMID:24136188 Ugp2 Rat glycochenodeoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat glycocholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat glycodeoxycholic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat haloperidol increases expression ISO UGP2 (Homo sapiens) 6480464 Haloperidol results in increased expression of UGP2 protein CTD PMID:34122009 Ugp2 Rat ivermectin affects expression ISO UGP2 (Homo sapiens) 6480464 Ivermectin affects the expression of UGP2 protein CTD PMID:32959892 Ugp2 Rat microcystin-LR increases expression ISO Ugp2 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of UGP2 mRNA CTD PMID:17654400 Ugp2 Rat N-methylformamide increases expression ISO Ugp2 (Mus musculus) 6480464 methylformamide analog results in increased expression of UGP2 mRNA and methylformamide results in increased expression of UGP2 mRNA CTD PMID:17040096 Ugp2 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of UGP2 protein CTD PMID:20935162 Ugp2 Rat nicotine increases expression ISO UGP2 (Homo sapiens) 6480464 Nicotine results in increased expression of UGP2 mRNA CTD PMID:18247414 Ugp2 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of UGP2 mRNA CTD PMID:33484710 Ugp2 Rat obeticholic acid increases expression ISO UGP2 (Homo sapiens) 6480464 obeticholic acid results in increased expression of UGP2 mRNA CTD PMID:27939613 Ugp2 Rat ozone multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of UGP2 mRNA more ... CTD PMID:32699268 and PMID:35430440 Ugp2 Rat paracetamol decreases expression ISO UGP2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of UGP2 mRNA CTD PMID:21420995 and PMID:29067470 Ugp2 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of UGP2 mRNA CTD PMID:33387578 Ugp2 Rat paracetamol multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of UGP2 mRNA CTD PMID:33819548 Ugp2 Rat perfluorohexanesulfonic acid increases expression ISO Ugp2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of UGP2 mRNA CTD PMID:37995155 Ugp2 Rat perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of UGP2 protein CTD PMID:34958885 Ugp2 Rat phenobarbital multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of UGP2 protein CTD PMID:20935162 Ugp2 Rat pirinixic acid multiple interactions ISO Ugp2 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of UGP2 mRNA CTD PMID:19710929 Ugp2 Rat pirinixic acid decreases expression ISO Ugp2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of UGP2 mRNA CTD PMID:18445702 more ... Ugp2 Rat quercetin decreases expression ISO UGP2 (Homo sapiens) 6480464 Quercetin results in decreased expression of UGP2 mRNA CTD PMID:21632981 Ugp2 Rat resveratrol decreases expression ISO UGP2 (Homo sapiens) 6480464 resveratrol results in decreased expression of UGP2 mRNA CTD PMID:12002526 Ugp2 Rat resveratrol multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of UGP2 mRNA CTD PMID:23557933 Ugp2 Rat SB 431542 multiple interactions ISO UGP2 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 Ugp2 Rat serpentine asbestos affects expression ISO UGP2 (Homo sapiens) 6480464 Asbestos and Serpentine affects the expression of UGP2 mRNA CTD PMID:24160326 Ugp2 Rat sodium arsenate increases expression ISO Ugp2 (Mus musculus) 6480464 sodium arsenate results in increased expression of UGP2 mRNA CTD PMID:21795629 Ugp2 Rat sodium arsenate decreases expression ISO Ugp2 (Mus musculus) 6480464 sodium arsenate results in decreased expression of UGP2 mRNA CTD PMID:30953684 Ugp2 Rat sodium chloride multiple interactions ISO UGP2 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UGP2 protein more ... CTD PMID:38598786 Ugp2 Rat sunitinib decreases expression ISO UGP2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of UGP2 mRNA CTD PMID:31533062 Ugp2 Rat tanespimycin decreases expression ISO UGP2 (Homo sapiens) 6480464 tanespimycin results in decreased expression of UGP2 protein CTD PMID:31370342 Ugp2 Rat tetrachloromethane affects expression ISO Ugp2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of UGP2 mRNA CTD PMID:17484886 Ugp2 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of UGP2 mRNA CTD PMID:34492290 Ugp2 Rat thiram increases expression ISO UGP2 (Homo sapiens) 6480464 Thiram results in increased expression of UGP2 mRNA CTD PMID:38568856 Ugp2 Rat titanium dioxide decreases methylation ISO Ugp2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of UGP2 gene and titanium dioxide results in decreased methylation of UGP2 promoter CTD PMID:35295148 Ugp2 Rat trichostatin A decreases expression ISO UGP2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of UGP2 mRNA CTD PMID:24935251 Ugp2 Rat trichostatin A increases expression ISO UGP2 (Homo sapiens) 6480464 trichostatin A results in increased expression of UGP2 mRNA CTD PMID:24935251 Ugp2 Rat triclosan decreases expression ISO UGP2 (Homo sapiens) 6480464 Triclosan results in decreased expression of UGP2 mRNA CTD PMID:30510588 Ugp2 Rat troglitazone decreases expression ISO Ugp2 (Mus musculus) 6480464 troglitazone results in decreased expression of UGP2 mRNA CTD PMID:28973697 Ugp2 Rat valproic acid affects expression ISO Ugp2 (Mus musculus) 6480464 Valproic Acid affects the expression of UGP2 mRNA CTD PMID:17963808 Ugp2 Rat valproic acid multiple interactions ISO UGP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UGP2 mRNA CTD PMID:27188386 Ugp2 Rat valproic acid affects expression ISO UGP2 (Homo sapiens) 6480464 Valproic Acid affects the expression of UGP2 mRNA CTD PMID:25979313 Ugp2 Rat valproic acid decreases expression ISO UGP2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of UGP2 mRNA CTD PMID:24935251 Ugp2 Rat vancomycin increases expression ISO Ugp2 (Mus musculus) 6480464 Vancomycin results in increased expression of UGP2 mRNA CTD PMID:18930951 Ugp2 Rat vanillin increases expression ISO UGP2 (Homo sapiens) 6480464 vanillin results in increased expression of UGP2 mRNA CTD PMID:17178418 Ugp2 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of UGP2 mRNA CTD PMID:23034163 more ...